Prudential Financial Inc Innoviva, Inc. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

A detailed history of Prudential Financial Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 69,876 shares of INVA stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,876
Previous 60,683 15.15%
Holding current value
$1.34 Million
Previous $995,000 35.48%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$16.33 - $20.04 $150,121 - $184,227
9,193 Added 15.15%
69,876 $1.35 Million
Q2 2024

Aug 13, 2024
SELL
$14.4 - $16.4 $64,008 - $72,898
-4,445 Reduced 6.83%
60,683 $995,000
Q1 2024

May 14, 2024
SELL
$14.56 - $16.78 $99,328 - $114,473
-6,822 Reduced 9.48%
65,128 $992,000
Q4 2023

Feb 13, 2024
BUY
$12.32 - $16.27 $46,310 - $61,158
3,759 Added 5.51%
71,950 $1.15 Million
Q3 2023

Nov 13, 2023
SELL
$12.37 - $13.89 $66,191 - $74,325
-5,351 Reduced 7.28%
68,191 $885,000
Q2 2023

Aug 11, 2023
BUY
$11.39 - $13.72 $141,110 - $169,977
12,389 Added 20.26%
73,542 $936,000
Q1 2023

May 12, 2023
SELL
$10.73 - $13.6 $98,200 - $124,467
-9,152 Reduced 13.02%
61,153 $687,000
Q4 2022

Feb 14, 2023
BUY
$11.8 - $13.78 $80,948 - $94,530
6,860 Added 10.81%
70,305 $0
Q3 2022

Nov 04, 2022
SELL
$11.61 - $15.22 $5,108 - $6,696
-440 Reduced 0.69%
63,445 $737,000
Q2 2022

Aug 15, 2022
SELL
$14.32 - $19.88 $1,575 - $2,186
-110 Reduced 0.17%
63,885 $943,000
Q1 2022

May 13, 2022
SELL
$15.39 - $20.25 $755,649 - $994,275
-49,100 Reduced 43.41%
63,995 $1.24 Million
Q4 2021

Feb 14, 2022
SELL
$15.91 - $18.72 $364,911 - $429,361
-22,936 Reduced 16.86%
113,095 $1.95 Million
Q3 2021

Nov 15, 2021
BUY
$13.06 - $17.24 $201,528 - $266,030
15,431 Added 12.8%
136,031 $2.27 Million
Q2 2021

Aug 16, 2021
BUY
$11.45 - $13.96 $537,279 - $655,059
46,924 Added 63.69%
120,600 $1.62 Million
Q1 2021

May 12, 2021
SELL
$11.06 - $12.87 $340,913 - $396,704
-30,824 Reduced 29.5%
73,676 $880,000
Q4 2020

Feb 16, 2021
SELL
$9.33 - $12.48 $1.12 Million - $1.5 Million
-120,175 Reduced 53.49%
104,500 $1.3 Million
Q3 2020

Nov 16, 2020
BUY
$10.33 - $14.49 $1.06 Million - $1.49 Million
102,740 Added 84.26%
224,675 $2.35 Million
Q2 2020

Aug 12, 2020
SELL
$11.49 - $15.26 $203,602 - $270,407
-17,720 Reduced 12.69%
121,935 $1.7 Million
Q1 2020

May 12, 2020
SELL
$8.11 - $15.23 $873,811 - $1.64 Million
-107,745 Reduced 43.55%
139,655 $1.64 Million
Q4 2019

Feb 11, 2020
BUY
$10.28 - $14.38 $8,892 - $12,438
865 Added 0.35%
247,400 $3.5 Million
Q3 2019

Nov 13, 2019
BUY
$10.05 - $14.55 $1.05 Million - $1.52 Million
104,319 Added 73.35%
246,535 $2.6 Million
Q2 2019

Aug 08, 2019
BUY
$13.1 - $14.95 $69,692 - $79,534
5,320 Added 3.89%
142,216 $0
Q1 2019

May 15, 2019
SELL
$13.69 - $20.06 $24,272 - $35,566
-1,773 Reduced 1.28%
136,896 $0
Q4 2018

Feb 07, 2019
BUY
$13.96 - $18.26 $296,915 - $388,371
21,269 Added 18.12%
138,669 $2.42 Million
Q3 2018

Nov 07, 2018
SELL
$13.63 - $15.7 $37,346 - $43,018
-2,740 Reduced 2.28%
117,400 $0
Q2 2018

Aug 13, 2018
SELL
$13.44 - $17.59 $1.29 Million - $1.68 Million
-95,781 Reduced 44.36%
120,140 $0
Q1 2018

May 04, 2018
BUY
$13.8 - $16.99 $1.33 Million - $1.64 Million
96,490 Added 80.79%
215,921 $0
Q4 2017

Feb 13, 2018
SELL
$11.73 - $14.75 $50,556 - $63,572
-4,310 Reduced 3.48%
119,431 $1.7 Million
Q3 2017

Nov 02, 2017
BUY
$12.06 - $14.12 $1.49 Million - $1.75 Million
123,741
123,741 $1.75 Million

Others Institutions Holding INVA

# of Institutions
227
Shares Held
79M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.34B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email